Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 5.60
- Piotroski Score 6.00
- Grade Outperform
- Symbol (MCK)
- Company McKesson Corporation
- Price $621.63
- Changes Percentage (0.05%)
- Change $0.34
- Day Low $620.23
- Day High $627.83
- Year High $637.51
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
- Last Earnings 10/31/2024
- Ex-Dividend for 5/16 Dividend 12/02/2024
- Dividend Payable 01/02/2025
- Today N/A
- Next Earnings (Estimated) 02/05/2025
- Fiscal Year End N/A
- Average Stock Price Target $574.50
- High Stock Price Target $715.00
- Low Stock Price Target $257.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $22.39
- Trailing P/E Ratio 26.21
- Forward P/E Ratio 26.21
- P/E Growth 26.21
- Net Income $3.00 B
Income Statement
Quarterly
Annual
Latest News of MCK
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Freemantle scores 17, McKnight 14 as No. 22 Xavier holds on to beat SC State
Xavier narrowly defeated South Carolina State 71-68 with Freemantle scoring 17 points. The Musketeers bounced back from a loss to Michigan, improving their record to 7-1. Croskey led the Bulldogs with...
By AP NEWS | 1 day ago -
McKeithan leads La Salle against Temple after 27-point game
La Salle faces Temple with McKeithan leading the Explorers to a 3-0 home record. La Salle averages 78.9 points per game, while Temple struggles on the road, giving up 72.5 points. Mashburn Jr....
By AP NEWS | 4 days ago -
Employee hospitalized following explosion at GM's Detroit-Hamtramck Assembly Center
An employee at a General Motors factory in Detroit was hospitalized after a cylinder exploded, not related to an electric vehicle battery. The incident at Factory ZERO resulted in non-life-threatening...
By CBS News | 4 days ago
